Ellipro scores of donor epitope specific HLA antibodies are not associated with kidney graft survival
- PMID: 38226401
- DOI: 10.1111/tan.15297
Ellipro scores of donor epitope specific HLA antibodies are not associated with kidney graft survival
Abstract
In kidney transplantation, donor HLA antibodies are a risk factor for graft loss. Accessibility of donor eplets for HLA antibodies is predicted by the ElliPro score. The clinical usefulness of those scores in relation to transplant outcome is unknown. In a large Dutch kidney transplant cohort, Ellipro scores of pretransplant donor antibodies that can be assigned to known eplets (donor epitope specific HLA antibodies [DESAs]) were compared between early graft failure and long surviving deceased donor transplants. We did not observe a significant Ellipro score difference between the two cohorts, nor significant differences in graft survival between transplants with DESAs having high versus low total Ellipro scores. We conclude that Ellipro scores cannot be used to identify DESAs associated with early versus late kidney graft loss in deceased donor transplants.
Keywords: DESA; Ellipro scores; kidney transplantation.
© 2023 The Authors. HLA: Immune Response Genetics published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Kamburova EG, Hoitsma A, Claas FH, Otten HG, PROCARE Consortium. Results and reflections from the PROfiling Consortium on Antibody Repertoire and Effector functions in kidney transplantation: a mini-review. HLA. 2019;94:129-140.
-
- Kumru Sahin G, Unterrainer C, Süsal C. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation. Transplant Rev (Orlando). 2020;34:100533.
-
- Delion A, Girerd S, Duarte K, et al. Which is the best predictor of de novo donor-specific antibodies in a cohort of non-sensitized first kidney transplantation: antigenic, allelic, epitope, or physiochemical HLA mismatches? Clin Transplant. 2019;33:e13508.
-
- Bezstarosti S, Kramer CSM, Claas FHJ, de Fijter JW, Reinders MEJ, Heidt S. Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes. Hum Immunol. 2022;83:256-263.
-
- Thornton JM, Edwards MS, Taylor WR, Barlow DJ. Location of ‘continuous’ antigenic determinants in the protruding regions of proteins. EMBO J. 1986;5:409-413.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
